APA (7th ed.) Citation

Verbeek, J. G., Azarang, L., Pilli, L. E., De Jong, V. M., Jager, A., Linn, S. C., . . . Van Harten, W. H. (2024). High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: A discrete choice experiment among healthcare providers. Acta oncologica, 63(1), 701-709. https://doi.org/10.2340/1651-226X.2024.40276

Chicago Style (17th ed.) Citation

Verbeek, Joost G.E., Leyla Azarang, Luis E. Pilli, Vincent M.T De Jong, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, and Wim H. Van Harten. "High-dose Chemotherapy for Patients with Stage III Breast Cancer with Homologous Recombination Deficiency: A Discrete Choice Experiment Among Healthcare Providers." Acta Oncologica 63, no. 1 (2024): 701-709. https://doi.org/10.2340/1651-226X.2024.40276.

MLA (9th ed.) Citation

Verbeek, Joost G.E., et al. "High-dose Chemotherapy for Patients with Stage III Breast Cancer with Homologous Recombination Deficiency: A Discrete Choice Experiment Among Healthcare Providers." Acta Oncologica, vol. 63, no. 1, 2024, pp. 701-709, https://doi.org/10.2340/1651-226X.2024.40276.